Curis Company Profile (NASDAQ:CRIS)

About Curis

Curis, Inc. is a biotechnology company. The Company is engaged in the development and commercialization of drug candidates for the treatment of human cancers. The Company's drug candidate, CUDC-907, is an orally available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. Its product pipeline includes CA-170, which is an oral small molecule drug candidate; CA-4948, which is an oral small molecule drug candidate that is designed to inhibit the interleukin-1 receptor-associated kinase 4 (IRAK4) kinase; Erivedge, which is an orally bioavailable small molecule, and is designed to selectively inhibit the Hedgehog signaling pathway; CUDC-427, which is an oral, small molecule Smac mimetic that is designed to promote cancer cell death by antagonizing inhibitor of apoptosis (IAP) proteins, and CUDC-305, which is an oral HSP90 inhibitor for the development in advanced lung cancer.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: CRIS
CUSIP: 23126910

Key Metrics:

Previous Close: $2.61
50 Day Moving Average: $1.94
200 Day Moving Average: $1.78
52-Week Range: $1.25 - $3.18
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -7.22
P/E Growth: 0.00
Market Cap: $337.92M
Outstanding Shares: 129,472,000
Beta: 1.76

Profitability:

Net Margins: -526.72%
Return on Equity: -65.51%
Return on Assets: -44.09%

Debt:

Debt-to-Equity Ratio: 0.36%
Current Ratio: 5.70%
Quick Ratio: 5.70%

Additional Links:

Companies Related to Curis:

Consensus Ratings for Curis (NASDAQ:CRIS) (?)

Ratings Breakdown:	5 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$5.00 (92.31% upside)

Analysts' Ratings History for Curis (NASDAQ:CRIS)

Show:

Date	Firm	Action	Rating	Price Target
9/8/2016	FBR & Co	Reiterated Rating	Buy
9/7/2016	Robert W. Baird	Reiterated Rating	Outperform	$7.00
5/5/2016	Cowen and Company	Initiated Coverage	Outperform
3/1/2016	SunTrust Banks Inc.	Initiated Coverage	Buy	$3.00
2/29/2016	Roth Capital	Reiterated Rating	Buy	$5.00
7/6/2015	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform
5/16/2015	Stifel Nicolaus	Reiterated Rating	Hold

(Data available from 10/1/2014 forward)

Earnings History for Curis (NASDAQ:CRIS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/7/2016
8/4/2016	Q216	($0.09)	($0.09)	$2.05 million	$1.70 million	View	Listen
5/9/2016	Q116	($0.08)	($0.07)	$2.30 million	$1.70 million	View	Listen
2/29/2016	Q415	($0.12)	($0.10)	$2.98 million	$2.10 million	View	Listen
11/9/2015	Q315	($0.08)	($0.04)	$2.82 million	$2.00 million	View	N/A
8/6/2015	Q215	($0.06)	($0.06)	$3.50 million	$2.10 million	View	N/A
5/7/2015	Q115	($0.06)	($0.07)	$2.27 million	$1.17 million	View	N/A
2/24/2015	Q4 14	($0.07)	($0.07)	$2.69 million	$2.00 million	View	N/A
11/10/2014	Q314	($0.04)	($0.06)	$4.13 million	$1.80 million	View	N/A
8/7/2014	Q214	($0.05)	($0.02)	$3.46 million	$4.80 million	View	N/A
5/8/2014	Q114	($0.06)	($0.06)	$1.88 million	$1.30 million	View	N/A
2/20/2014	Q413	($0.08)	($0.05)	$1.59 million	$1.52 million	View	N/A
11/5/2013	Q313	($0.01)	($0.02)	$6.44 million	$7.20 million	View	N/A
8/5/2013	Q2 2013	($0.05)	($0.02)	$4.43 million	$5.40 million	View	N/A
4/30/2013	Q1 2013	($0.05)	($0.06)	$3.86 million	$0.90 million	View	N/A
2/20/2013	Q4 2012	($0.08)	($0.15)	$2.07 million	$1.69 million	View	N/A
11/6/2012	Q312	($0.08)	($0.04)	$1.01 million	$0.60 million	View	N/A
8/2/2012		($0.05)	($0.04)			View	N/A
5/8/2012		$0.02	$0.03			View	N/A
10/27/2011		($0.07)	($0.05)			View	N/A
7/28/2011		($0.07)	($0.06)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Curis (NASDAQ:CRIS)

Current Year EPS Consensus Estimate: $-0.38 EPS
Next Year EPS Consensus Estimate: $-0.36 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	4	($0.08)	($0.05)	($0.07)
Q2 2016	4	($0.10)	($0.05)	($0.08)
Q3 2016	4	($0.13)	($0.07)	($0.10)
Q4 2016	4	($0.12)	($0.07)	($0.09)

(Data provided by Zacks Investment Research)

Dividend History for Curis (NASDAQ:CRIS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Curis (NASDAQ:CRIS)

Insider Ownership Percentage: 6.09%
Institutional Ownership Percentage: 52.36%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/7/2016	Discovery Technologie Aurigene	Major Shareholder	Buy	10,208,333	$2.40	$24,499,999.20
5/27/2016	Martyn D Greenacre	Director	Sell	15,000	$1.69	$25,350.00
5/26/2016	Kenneth I Kaitin	Director	Sell	15,000	$1.76	$26,400.00
12/30/2015	Daniel R. Passeri	Director	Sell	14,400	$3.01	$43,344.00
12/29/2015	Daniel R. Passeri	Director	Sell	11,200	$2.91	$32,592.00
12/28/2015	Daniel R. Passeri	Director	Sell	13,600	$2.85	$38,760.00
12/23/2015	Daniel R. Passeri	Director	Sell	48,900	$2.78	$135,942.00
12/21/2015	Daniel R. Passeri	Director	Sell	289,000	$2.99	$864,110.00
8/27/2014	Ali Ph.D. Fattaey	CEO	Buy	62,890	$1.60	$100,624.00
12/11/2013	Ali Ph.D. Fattaey	COO	Buy	3,000	$2.52	$7,560.00
11/12/2013	Michael Gray	CFO	Buy	10,000	$2.86	$28,600.00
11/8/2013	Kenneth Pienta	Director	Buy	20,000	$2.95	$59,000.00
8/16/2013	James Mcnab	Director	Sell	50,000	$4.00	$200,000.00
12/6/2012	Daniel R Passeri	CEO	Buy	25,000	$3.03	$75,750.00

(Data available from 1/1/2013 forward)

Latest Headlines for Curis (NASDAQ:CRIS)

Date	Headline
	Catching the Wonder of Investors: Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 30 at 4:51 PM
	Intraday Active Biotech Stocks News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Curis, Inc. (NASDAQ:CRIS) - The Voice Registrar (NASDAQ:CRIS) voiceregistrar.com - September 30 at 4:51 PM
	Curis, Inc. (CRIS) Updated Broker Price Targets - The De Soto Edge (NASDAQ:CRIS) desotoedge.com - September 29 at 4:20 PM
	Featured Stock: Curis, Inc. (NASDAQ:CRIS), Banco Bilbao Viscaya Argentaria S.A. (NYSE:BBVA) - Newburgh Press (NASDAQ:CRIS) newburghpress.com - September 26 at 4:35 PM
	Biotech Stocks Worth a Closer Look: Curis, Inc. (NASDAQ:CRIS), Novavax, Inc. (NASDAQ:NVAX) - The Voice Registrar (NASDAQ:CRIS) voiceregistrar.com - September 26 at 4:35 PM
	Curis : Aurigene to Invest in Curis at Premium Through Waiver of Certain Milestone Payments Under Collaboration Agreement (NASDAQ:CRIS) www.4-traders.com - September 25 at 4:01 PM
	Biotech Stocks Worth a Closer Look: Curis, Inc. (NASDAQ:CRIS), PDL BioPharma, Inc. (NASDAQ:PDLI) - The Voice Registrar (NASDAQ:CRIS) voiceregistrar.com - September 21 at 4:57 PM
	Penny Stock Investors Take an Interest in Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 21 at 8:39 AM
	ETF’s with exposure to Curis, Inc. : September 19, 2016 (NASDAQ:CRIS) www.capitalcube.com - September 19 at 5:12 PM
	Investor's Watch: Curis, Inc. (NASDAQ:CRIS), Cara Therapeutics, Inc. (NASDAQ:CARA) - Newburgh Press (NASDAQ:CRIS) newburghpress.com - September 19 at 9:06 AM
	Intraday Active Biotech Stocks News: Editas Medicine Inc. (NASDAQ:EDIT), Curis, Inc. (NASDAQ:CRIS) - The Voice Registrar (NASDAQ:CRIS) voiceregistrar.com - September 19 at 9:06 AM
	Curis (CRIS) Shows Strength: Stock Adds 6.9% in Session (NASDAQ:CRIS) finance.yahoo.com - September 19 at 9:06 AM
	Keen Investors Seek Information on Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 16 at 4:14 PM
	Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:CRIS) www.publicnow.com - September 16 at 4:14 PM
	Stock Update, a Closer Look at Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 15 at 4:48 PM
	Now Available: Checkpoint Surgical LLC - Medical Equipment - Deals and Alliances Profile (NASDAQ:CRIS) reports.pr-inside.com - September 15 at 9:34 AM
	Keen Investors Narrowing Their Focus on Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 14 at 9:39 PM
	Placing Curis, Inc. (NASDAQ:CRIS) Shares Under the Microscope - Post News (NASDAQ:CRIS) www.kentuckypostnews.com - September 9 at 9:13 AM
	Curis, Inc. (NASDAQ:CRIS) From The Analysts Point of View - National Daily Press (NASDAQ:CRIS) www.nationaldailypress.com - September 9 at 9:13 AM
	Stock Showing Gains in Today's Session: Curis, Inc. (NASDAQ:CRIS) - Post News (NASDAQ:CRIS) www.kentuckypostnews.com - September 8 at 8:10 AM
	Robert W. Baird Reiterates Outperform at Curis Inc. (NASDAQ: CRIS) - BNB Daily (blog) (NASDAQ:CRIS) www.baseball-news-blog.com - September 8 at 8:10 AM
	Curis (CRIS) Partner Aurigene Discovery Receives 10.2M Shares at $2.40 in Lieu of Milestone Payment (NASDAQ:CRIS) www.streetinsider.com - September 7 at 4:30 PM
	OTC Investors Supremely Interested in Shares of Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 7 at 7:13 AM
	Company Update (NASDAQ:CRIS): Aurigene to Invest in Curis, Inc. at Premium Through Waiver of Certain Milestone ... - Smarter Analyst (NASDAQ:CRIS) www.smarteranalyst.com - September 7 at 7:13 AM
	6:56 am Curis announces its collaborator, Aurigene Discovery Technologies, will receive 10.2 million shares of its common stock, priced at $2.40/share, (NASDAQ:CRIS) finance.yahoo.com - September 7 at 7:13 AM
	Aurigene to Invest in Curis at Premium Through Waiver of Certain Milestone Payments Under Collaboration Agreement (NASDAQ:CRIS) www.publicnow.com - September 7 at 7:13 AM
	CURIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Oth (NASDAQ:CRIS) biz.yahoo.com - September 7 at 7:13 AM
	A Second Look at Shares of Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 2 at 4:11 PM
	Under the Magnifying Glass: A Closer Look at Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - September 1 at 4:20 PM
	Taking a Serious Look at Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 31 at 4:39 PM
	Zeroing Our Focus on Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 31 at 9:11 AM
	Curis to Present at Baird’s 2016 Global Healthcare Conference (NASDAQ:CRIS) finance.yahoo.com - August 31 at 9:11 AM
	Q2 2016 Curis Inc Earnings Conference Call (NASDAQ:CRIS) www.publicnow.com - August 31 at 9:11 AM
	ETF’s with exposure to Curis, Inc. : August 29, 2016 (NASDAQ:CRIS) www.capitalcube.com - August 29 at 4:37 PM
	Magnifying Stocks of Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 23 at 4:32 PM
	Let's Take a Closer Look at Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 23 at 8:37 AM
	Penny Stock Alert - Update & Review on This Stock: Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 19 at 8:30 PM
	Institutions Have Decreased Their Ownership of Curis, Inc. (NASDAQ:CRIS) - Post News (NASDAQ:CRIS) www.kentuckypostnews.com - August 19 at 3:30 PM
	Curis, Inc. (NASDAQ:CRIS) Shares in Focus According to the Crowd & Analysts - Post News (NASDAQ:CRIS) www.kentuckypostnews.com - August 19 at 10:20 AM
	A Closer Look at Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 16 at 9:42 PM
	Small Cap Update on: Curis, Inc. (NASDAQ:CRIS) - Duncan Research (NASDAQ:CRIS) www.duncanindependent.com - August 15 at 11:40 AM
	ETF’s with exposure to Curis, Inc. : August 15, 2016 (NASDAQ:CRIS) www.capitalcube.com - August 15 at 11:40 AM
	Curis, Inc. :CRIS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:CRIS) www.capitalcube.com - August 12 at 4:26 PM
	CURIS INC Financials (NASDAQ:CRIS) finance.yahoo.com - August 11 at 4:32 PM
	Edited Transcript of CRIS earnings conference call or presentation 4-Aug-16 12:30pm GMT (NASDAQ:CRIS) finance.yahoo.com - August 5 at 4:25 PM
	Curis' (CRIS) CEO Ali Fattaey on Q2 2016 Results - Earnings Call Transcript (NASDAQ:CRIS) seekingalpha.com - August 4 at 4:36 PM
	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (NASDAQ:CRIS) www.rttnews.com - August 4 at 10:49 AM
	Curis Reports Second Quarter 2016 Financial Results (NASDAQ:CRIS) globenewswire.com - August 4 at 10:49 AM
	Curis Inc.: View all press releases » (NASDAQ:CRIS) www.twst.com - August 4 at 10:49 AM
	Curis reports 2Q loss (NASDAQ:CRIS) sg.finance.yahoo.com - August 4 at 10:49 AM